Why patients with inflammatory bowel disease are at increased risk for thrombosis is unknown. Since they may have impaired absorption of vitamins that regulate the metabolism of homocysteine, we tested the hypothesis that they have hyperhomocysteinemia, an established risk factor for arterial and venous thrombosis.
High prevalence of hyperchomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications? / M. Cattaneo, M. Vecchi, M. L. Zighetti, S. Saibeni, I. Martinelli, P. Omodei, P. M. Mannucci, R. de Franchis. - In: THROMBOSIS AND HAEMOSTASIS. - ISSN 0340-6245. - 80:4(1998 Oct), pp. 542-545.
High prevalence of hyperchomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications?
M. CattaneoPrimo
;M. VecchiSecondo
;R. de FranchisUltimo
1998
Abstract
Why patients with inflammatory bowel disease are at increased risk for thrombosis is unknown. Since they may have impaired absorption of vitamins that regulate the metabolism of homocysteine, we tested the hypothesis that they have hyperhomocysteinemia, an established risk factor for arterial and venous thrombosis.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
